Insider Transactions in Q2 2023 at Emergent Bio Solutions Inc. (EBS)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2023
|
Robert Kramer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
212,308
+19.06%
|
-
|
|
Jun 09
2023
|
Adam Havey EVP, Business Operations |
BUY
Grant, award, or other acquisition
|
Direct |
73,847
+19.22%
|
-
|
|
Jun 09
2023
|
Richard S Lindahl EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,847
+19.37%
|
-
|
|
Jun 09
2023
|
Jennifer Lynne Fox EVP, Ext Aff, GC, Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
73,847
+18.74%
|
-
|
|
Jun 09
2023
|
Coleen Glessner EVP, Quality & Ethics, and CPL |
BUY
Grant, award, or other acquisition
|
Direct |
46,155
+12.97%
|
-
|
|
Jun 09
2023
|
Paul Anthony Williams SVP, Products Business |
BUY
Grant, award, or other acquisition
|
Direct |
13,847
+23.7%
|
-
|
|
Jun 02
2023
|
Kathryn C Zoon Director |
SELL
Open market or private sale
|
Direct |
1,830
-3.53%
|
$14,640
$8.35 P/Share
|
|
May 25
2023
|
Kathryn C Zoon Director |
SELL
Open market or private sale
|
Direct |
1,700
-3.18%
|
$13,600
$8.38 P/Share
|
|
May 25
2023
|
Kathryn C Zoon Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,847
+38.75%
|
-
|
|
May 25
2023
|
Zsolt Harsanyi Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
33,847
+32.01%
|
-
|
|
May 25
2023
|
Keith Katkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,847
+44.37%
|
-
|
|
May 25
2023
|
Ronald Richard Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,847
+38.67%
|
-
|
|
May 25
2023
|
Louis W Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,847
+27.95%
|
-
|
|
May 25
2023
|
Jerome M Hauer Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,847
+37.05%
|
-
|
|
May 25
2023
|
Marvin L White Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,847
+39.92%
|
-
|
|
May 25
2023
|
Sujata Tyagi Dayal Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,847
+42.55%
|
-
|
|
Apr 07
2023
|
Coleen Glessner EVP, Quality & Ethics, and CPL |
BUY
Payment of exercise price or tax liability
|
Direct |
480
+0.4%
|
-
|